DLD Antikörper
Kurzübersicht für DLD Antikörper (ABIN7266766)
Target
Alle DLD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- DLDH/DLD Rabbit mAb
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Monoclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthesized peptide derived from human DLDH/DLD
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
-
Andere Bezeichnung
- DLD
-
Hintergrund
- This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014],DLDD, DLDH, E3, GCSL, LAD, PHE3,Amino acid metabolism,Cancer,Carbohydrate metabolism,Endocrine & Metabolism,Signal Transduction,DLD
-
Molekulargewicht
- 56kDa
-
Gen-ID
- 1738
-
UniProt
- P09622
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Target
-